Profile picture

Doctor Lucas Xing

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
Follow
Biography
MD, PhD (Department of Cardiology, Copenhagen University Hospital, Copenhagen, Denmark).
Logo ESC

Contributor content

AF screening yield according to methodology and population characteristics
Presentation
AF screening yield according to methodology and population characteristics
Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation - insights from the LAAOS-III trial
Presentation
Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation - insights from the LAAOS-III trial
Effects of long-term continuous screening for atrial fibrillation on heart failure events - results from the randomized LOOP Study
Presentation
Effects of long-term continuous screening for atrial fibrillation on heart failure events - results from the randomized LOOP Study
Electrocardiographic markers of subclinical atrial fibrillation detected by implantable loop recorder
Presentation
Electrocardiographic markers of subclinical atrial fibrillation detected by implantable loop recorder
Morphology-Voltage-P-wave-duration (MVP) score to select patients for continuous atrial fibrillation screening to prevent stroke
Presentation
Morphology-Voltage-P-wave-duration (MVP) score to select patients for continuous atrial fibrillation screening to prevent stroke
Screening for atrial fibrillation to prevent stroke in elderly individuals with or without preexisting cardiovascular disease
Presentation
Screening for atrial fibrillation to prevent stroke in elderly individuals with or without preexisting cardiovascular disease
Systolic blood pressure and effects of screening for atrial fibrillation with long-term continuous monitoring
Presentation
Systolic blood pressure and effects of screening for atrial fibrillation with long-term continuous monitoring
Dose adjustment of non-vitamin K antagonist oral anticoagulants following acute coronary syndrome and percutaneous coronary intervention in patients with atrial fibrillation
Presentation
Dose adjustment of non-vitamin K antagonist oral anticoagulants following acute coronary syndrome and percutaneous coronary intervention in patients with atrial fibrillation

ESC 365 is supported by